Allergy Therapeutics names Llobet CEO

Allergy vaccine company Allergy Therapeutics plc (LSE:AGY) hired Manuel Llobet as CEO. Llobet, who also becomes an executive director, replaces Keith Carter, who becomes a non-executive director. The management changes were proposed in June (See BioCentury Extra, Friday, June 12, 2009). ...